These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 23186063)

  • 1. Occurrence and determinants of poor response to short-term pre-operative erythropoietin treatment.
    van Haelst IM; Egberts AC; Doodeman HJ; van Solinge WW; Kalkman CJ; Bennis M; Traast HS; van Klei WA
    Acta Anaesthesiol Scand; 2013 Mar; 57(3):350-7. PubMed ID: 23186063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An individualized pre-operative blood saving protocol can increase pre-operative haemoglobin levels and reduce the need for transfusion in elective total hip or knee arthroplasty.
    Gonzalez-Porras JR; Colado E; Conde MP; Lopez T; Nieto MJ; Corral M
    Transfus Med; 2009 Feb; 19(1):35-42. PubMed ID: 19302453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative intravenous iron preserves iron stores and may hasten the recovery from post-operative anaemia after knee replacement surgery.
    García-Erce JA; Cuenca J; Martínez F; Cardona R; Pérez-Serrano L; Muñoz M
    Transfus Med; 2006 Oct; 16(5):335-41. PubMed ID: 16999756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic blood transfusion reduction by risk-based protocol in total joint arthroplasty.
    Rashiq S; Jamieson-Lega K; Komarinski C; Nahirniak S; Zinyk L; Finegan B
    Can J Anaesth; 2010 Apr; 57(4):343-9. PubMed ID: 20099050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood transfusion requirement prediction in patients undergoing primary total hip and knee arthroplasty.
    Guerin S; Collins C; Kapoor H; McClean I; Collins D
    Transfus Med; 2007 Feb; 17(1):37-43. PubMed ID: 17266702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery.
    Yoo YC; Shim JK; Kim JC; Jo YY; Lee JH; Kwak YL
    Anesthesiology; 2011 Nov; 115(5):929-37. PubMed ID: 22027622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of a preoperative erythropoietin protocol as part of a multifaceted blood management program in daily clinical practice (CME).
    Doodeman HJ; van Haelst IM; Egberts TC; Bennis M; Traast HS; van Solinge WW; Kalkman CJ; van Klei WA
    Transfusion; 2013 Sep; 53(9):1930-9. PubMed ID: 23240859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
    Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
    Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluctuations in haemoglobin levels in haemodialysis, pre-dialysis and peritoneal dialysis patients receiving epoetin alpha or darbepoetin alpha.
    Walker R; Pussell BA;
    Nephrology (Carlton); 2009 Oct; 14(7):689-95. PubMed ID: 19796029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of preoperative intravenous erythropoietin plus iron on outcome in anemic patients after cardiac valve replacement.
    Cladellas M; Farré N; Comín-Colet J; Gómez M; Meroño O; Bosch MA; Vila J; Molera R; Segovia A; Bruguera J
    Am J Cardiol; 2012 Oct; 110(7):1021-6. PubMed ID: 22771376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
    Phair JP; Abels RI; McNeill MV; Sullivan DJ
    Arch Intern Med; 1993 Dec; 153(23):2669-75. PubMed ID: 8250662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Darbepoetin alfa effectively maintains haemoglobin concentrations at extended dose intervals relative to intravenous or subcutaneous recombinant human erythropoietin in dialysis patients.
    Brunkhorst R; Bommer J; Braun J; Haag-Weber M; Gill C; Wagner J; Wagener T;
    Nephrol Dial Transplant; 2004 May; 19(5):1224-30. PubMed ID: 14993489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Erythropoietin alone or as an adjuvant for the autologous blood donation program in major orthopedic surgery].
    Bisbe E; Sáez M; Nomen N; Castillo J; Santiveri X; Mestre C; Cano X
    Rev Esp Anestesiol Reanim; 2003 Oct; 50(8):395-400. PubMed ID: 14601367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.
    Musto P; Sanpaolo G; D'Arena G; Scalzulli PR; Matera R; Falcone A; Bodenizza C; Perla G; Carotenuto M
    Haematologica; 2001 Jan; 86(1):44-51. PubMed ID: 11146570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of administration of recombinant human erythropoietin in acute normovolemic hemodilution on transfusion needs during total hip prosthesis implantation].
    Beris P; Samii K; de Pree C; Matthes T; Gamulin Z; Hoffmeyer P
    Schweiz Med Wochenschr; 1998 Oct; 128(42):1582-6. PubMed ID: 9824886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Do baseline haemoglobin-rates point to the efficacy of blood saving techniques?].
    Redl G; Trauner S; Cumlivski R; Fuchs R
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Aug; 36(8):465-70. PubMed ID: 11573126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemoglobin targets and blood transfusions in hemodialysis patients without symptomatic cardiac disease receiving erythropoietin therapy.
    Foley RN; Curtis BM; Parfrey PS
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1669-75. PubMed ID: 18922988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-operative injections of epoetin-alpha versus post-operative retransfusion of autologous shed blood in total hip and knee replacement: a prospective randomised clinical trial.
    Moonen AF; Thomassen BJ; Knoors NT; van Os JJ; Verburg AD; Pilot P
    J Bone Joint Surg Br; 2008 Aug; 90(8):1079-83. PubMed ID: 18669967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum erythropoietin and creatinine concentrations as predictive factors for response to recombinant human erythropoietin treatment in anaemic tumour patients on chemotherapy.
    Fjornes T; Wiedemann GJ; Sack K; Jelkmann W
    Oncol Rep; 1998; 5(1):81-6. PubMed ID: 9458299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose recombinant human erythropoietin for treatment of anemia in myelodysplastic syndromes and paroxysmal nocturnal hemoglobinuria: a pilot study.
    Stebler C; Tichelli A; Dazzi H; Gratwohl A; Nissen C; Speck B
    Exp Hematol; 1990 Dec; 18(11):1204-8. PubMed ID: 2226680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.